SURAKSHA DIAGNOSTIC LIMITED (SURAKSHA) Share Price Rises 13.14% Today

SURAKSHA DIAGNOSTIC LIMITED traded at Rs 306, up 13.14% today, with a market capitalisation of Rs 1,343.94 crore.

SURAKSHA Share Price moved sharply higher in today’s session, with SURAKSHA DIAGNOSTIC LIMITED trading at Rs 306, up 13.14% or Rs 35.55 from the previous close of Rs 270.45. The company’s market capitalisation stood at Rs 1,343.94 crore at the time of this update, placing it in the Small Cap category. In Stock Market Today activity, that makes the counter one of the notable Stocks in News and a top gainer within its size bracket.

The move is relevant not because of speculation, but because verified market data shows a clear single-day price rise backed by active trading. The stock opened at Rs 274, touched an intraday high of Rs 308.45 and a low of Rs 271.35, indicating that buyers kept the price elevated through the morning range. Total traded volume stood at 11,71,023 shares, including 11,28,409 shares on NSE and 42,614 shares on BSE, while reported turnover was Rs 1.3 crore on the exchange volume source used here.

For readers tracking SURAKSHA Share Price Today, the supplied data confirms what happened but does not establish a company-specific catalyst behind the move. That means the verified story is the price action itself: a strong share price gain, higher trading participation and a stock that has clearly entered the Market News conversation. In this Univest analysis, the next questions are whether the valuation supports investor attention, how the business compares with its industry benchmarks, and what peer metrics say about SURAKSHA DIAGNOSTIC LIMITED’s current market position.

SURAKSHA DIAGNOSTIC LIMITED (SURAKSHA) Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 306
Previous Close	Rs 270.45
Today's Change	+Rs 35.55 (+13.14%)
Day Open	Rs 274
Day High	Rs 308.45
Day Low	Rs 271.35
Current Volume (BSE)	42,614
BSE Traded Volume	42,614
NSE Traded Volume	11,28,409
Combined NSE + BSE Volume	11,71,023
Turnover	Rs 1.3 crore
Market Capitalisation	Rs 1,343.94 crore
Market Cap Category	Small Cap

SURAKSHA DIAGNOSTIC LIMITED (SURAKSHA) traded at Rs 306. versus the previous close of Rs 270.45, a rise of 13.14%. The stock opened at Rs 274, reached Rs 308.45, touched Rs 271.35. Reported volume was 42,614.

SURAKSHA DIAGNOSTIC LIMITED (SURAKSHA) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 1,343.94 crore
P/E Ratio	41.35x
P/B Ratio	5.64x
ROE	13.93%
ROCE	22.94%
EPS	Rs 6.54
Dividend Yield	0.18%

SURAKSHA DIAGNOSTIC LIMITED was valued at a P/E ratio of 41.35x, a P/B ratio of 5.64x. These multiples provide valuation context, but they should not be labelled expensive or inexpensive without a comparable peer or sector benchmark.

Profitability and capital efficiency were represented by ROE of 13.93% and ROCE of 22.94%. ROE relates profit to shareholder equity, while ROCE measures returns generated on the capital employed in the business.

Per-share and shareholder-return metrics included EPS of Rs 6.54, dividend yield of 0.18%. Dividend yield is a current or historical ratio and does not guarantee future distributions.

SURAKSHA Fundamental Analysis shows a small-cap Healthcare company that is already trading on visible profitability metrics, but also at valuation multiples that deserve closer comparison with its industry set. At a market capitalisation of Rs 1,343.94 crore and a price of Rs 306, the stock is priced at a P/E ratio of 41.35 and a P/B ratio of 5.64. On standalone interpretation, those are simply valuation markers; whether they look demanding or reasonable depends on sector and peer context.

Dividend yield is 0.18, a modest historical/current payout measure relative to the current market price. For investors looking at SURAKSHA Earnings or SURAKSHA Financial Results in a broader sense, that yield indicates the present market case is more centred on valuation and operating returns than on income distribution. The stock’s current pricing also means that each rupee of earnings is being valued at 41.35 times, so investor attention naturally shifts toward whether profitability quality and industry positioning justify that multiple.

This is where Univest sees the balance of the data as mixed rather than one-directional. ROCE at 22.94% is healthy, and ROE at 13.93% is respectable. But the P/E ratio of 41.35 and P/B of 5.64 place the stock in a bracket where relative comparisons matter. In other words, SURAKSHA Share Price is not just about today’s rally; it is also about how the market is valuing the company versus others in Hospital & Healthcare Services. That makes the sector and peer sections especially important in any neutral stock analysis.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Hospital & Healthcare Services
Benchmark Scope	same industry
Company P/E Ratio	41.35x
Benchmark Median P/E	26.91x
Benchmark Average P/E	117.14x
Benchmark P/E Range	8.67x to 1,632.51x
Company P/B Ratio	5.64x
Benchmark Median P/B	2.14x
Company ROE	13.93%
Benchmark Median ROE	14.66%
Company ROCE	22.94%
Benchmark Median ROCE	18.85%
Company Market Capitalisation	Rs 1,343.94 crore
Benchmark Median Market Cap	Rs 101.28 crore

SURAKSHA DIAGNOSTIC LIMITED (SURAKSHA) is classified under sector: Healthcare and industry: Hospital & Healthcare Services.

SURAKSHA DIAGNOSTIC LIMITED (SURAKSHA) has a P/E ratio of 41.35x, which is above the benchmark median of 26.91x, a difference of +53.66%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

SURAKSHA DIAGNOSTIC LIMITED (SURAKSHA) has a ROE of 13.93%, which is below the benchmark median of 14.66%, a difference of -4.98%. SURAKSHA DIAGNOSTIC LIMITED (SURAKSHA) has a ROCE of 22.94%, which is above the benchmark median of 18.85%, a difference of +21.7%.

Track today's top gainers through the Univest top gainers screener. The peer table below provides the company-level comparison.

SURAKSHA DIAGNOSTIC LIMITED operates in Healthcare, specifically the Hospital & Healthcare Services industry. The benchmark supplied here covers the same industry and includes 40 companies, making it a useful frame for comparing valuation, profitability and size rather than relying on generic sector commentary.

Within this benchmark, SURAKSHA Share Price carries a company P/E of 41.35. That is above the industry median P/E of 26.91, but well below the industry average of 117.14. The average is clearly influenced by wide dispersion, since the benchmark P/E range runs from 8.67 to 1,632.51 across 32 companies with available P/E data. This tells readers that the industry contains both modestly valued and highly valued businesses, so the company sits above the median but nowhere near the extreme end of the range.

The valuation picture is similar on price-to-book. SURAKSHA’s P/B ratio of 5.64 is above the benchmark median of 2.14 and the average of 2.67 across 40 companies. The sector range stretches from -9.38 to 11.99, so the stock is positioned in the upper part of the pack on this measure. That indicates the market is assigning a richer balance-sheet multiple to the company than it does to a typical peer in the same industry group.

Profitability tells a more nuanced story. The company’s ROE of 13.93% is slightly below the benchmark median of 14.66% and far below the average of 36.33%. However, its ROCE of 22.94% is above the median of 18.85% and above the average of 21.42%. Market capitalisation also stands out: at Rs 1,343.94 crore, the company is far above the benchmark median market cap of Rs 101.28 crore and also above the average of Rs 452.71 crore, though below the maximum of Rs 2,596.51 crore. For Univest readers, that means SURAKSHA Share Price is being assessed as a relatively larger industry participant with stronger-than-median capital efficiency but above-median valuation multiples.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Dr Agarwals Eye Hospital Ltd.	DRAGARWQ	2,596.51	34.07	7.02	-2.6	16.92
KMC Speciality Hospitals (India) Ltd.	KMCSHIL	2,019.81	43.22	9.6	22.42	25.85
Krsnaa Diagnostics Ltd.	KRSNAA	1,866.03	18.15	1.88	0	129.09
Shalby Ltd.	SHALBY	1,746.52	15.02	1.36	5.19	6.85
GPT Healthcare Ltd.	GPTHEALTH	1,319.44	27.26	4.57	33.06	25.56

SURAKSHA DIAGNOSTIC LIMITED (SURAKSHA) has a P/E ratio of 41.35x compared with the displayed peer median of 27.26x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 13.93% compares with a peer median of 5.19% across the companies shown in the table. ROCE stood at 22.94% versus the displayed peer median of 25.56%, providing a capital-efficiency comparison. SURAKSHA DIAGNOSTIC LIMITED (SURAKSHA) has a market capitalisation of Rs 1,343.94 crore. Among the 5 peers shown, 4 have a larger market capitalisation.

SURAKSHA Share Price becomes more interesting when placed alongside listed peers in Hospital & Healthcare Services. Compared with Dr Agarwals Eye Hospital Ltd., which has a market cap of Rs 2,596.51 crore, SURAKSHA is smaller at Rs 1,343.94 crore, but its ROE of 13.93% is materially stronger than Dr Agarwals’ -2.6%. Its ROCE of 22.94% is also above Dr Agarwals’ 16.92%, even though Dr Agarwals trades at a lower P/E of 34.07 and a higher P/B of 7.02.

Against KMC Speciality Hospitals (India) Ltd., the comparison is tighter on valuation. KMC trades at 43.22 times earnings versus SURAKSHA at 41.35, but KMC shows a stronger ROE of 22.42% and ROCE of 25.85%. That suggests SURAKSHA is near KMC on earnings multiple while trailing it on reported profitability returns. GPT Healthcare Ltd., on the other hand, has a market cap of Rs 1,319.44 crore, very close to SURAKSHA’s Rs 1,343.94 crore. Yet GPT trades at a lower P/E of 27.26 and P/B of 4.57 while posting higher ROE of 33.06% and ROCE of 25.56%.

Krsnaa Diagnostics Ltd. highlights another angle. It trades at a much lower P/E of 18.15 and P/B of 1.88, with ROE at 0 and ROCE at 129.09. Shalby Ltd. trades at 15.02 times earnings and 1.36 times book, with ROE of 5.19% and ROCE of 6.85%, suggesting a cheaper valuation but weaker profitability ratios. Unihealth Hospitals Ltd. trades at 44.01 times earnings and 8.34 times book, above SURAKSHA on both valuation measures, while showing ROE of 29.75% and ROCE of 20.33%.

The peer set therefore does not produce a single easy conclusion. Instead, it shows that SURAKSHA DIAGNOSTIC LIMITED sits in a middle band on market cap, above some peers and below others on valuation, and with operating-return metrics that are respectable but not dominant across the group. That is exactly why SURAKSHA Stock Analysis should not stop at today’s price rise alone.

Why Investors Are Watching SURAKSHA

SURAKSHA Share Price is in focus because today’s move combines a sharp price gain with meaningful trading activity and a valuation profile that sits above industry medians on key multiples. In Share Market Today discussions, that combination is enough to place the stock among active market movers even without a confirmed company-specific trigger in the supplied data.

• Verified price action: The stock rose 13.14% to Rs 306 from Rs 270.45, after opening at Rs 274 and touching Rs 308.45.
• Trading participation: Total volume reached 11,71,023 shares, including 11,28,409 on NSE and 42,614 on BSE.
• Fundamental context: The company trades at a P/E of 41.35, P/B of 5.64, ROE of 13.93% and ROCE of 22.94%.
• Sector positioning: Its P/E is above the same-industry median of 26.91, while its ROCE is above the benchmark median of 18.85%.
• Size and relevance: With a market cap of Rs 1,343.94 crore, it is a meaningful Small Cap name within Healthcare.

What investors may monitor next is whether SURAKSHA Share Price sustains attention as a top gainer after this initial move, and how future updates on profitability, valuation and industry comparisons evolve. Univest notes that the present dataset confirms the market move clearly, while the deeper investment debate remains centred on relative valuation and operating returns.

About SURAKSHA

SURAKSHA DIAGNOSTIC LIMITED is part of the Healthcare sector and operates within the Hospital & Healthcare Services industry. That industry classification places the company in a segment where investors often compare listed names using a mix of earnings valuation, price-to-book multiples and return ratios such as ROE and ROCE.

In market structure terms, the company is not among the smallest listed businesses in its industry set. Its market capitalisation of Rs 1,343.94 crore is far above the benchmark median of Rs 101.28 crore for the same industry and also above the benchmark average of Rs 452.71 crore. That indicates SURAKSHA DIAGNOSTIC LIMITED has a more meaningful market footprint than many smaller listed names in Hospital & Healthcare Services, even though it remains within the Small Cap category.

For readers following SURAKSHA Company News, the current data-driven profile is that of a Healthcare stock with moderate profitability and above-median valuation. Its ROE of 13.93% sits close to the sector median, while ROCE of 22.94% is better than the benchmark median. At the same time, the stock’s P/E of 41.35 and P/B of 5.64 indicate that the market is assigning a richer multiple than it does to the typical company in the peer universe. That combination explains why SURAKSHA Share News is being tracked closely in today’s Indian Stock Market update.

Track SURAKSHA Share Price on Univest

Use SURAKSHA DIAGNOSTIC LIMITED (SURAKSHA) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top gainers lists and related market analysis.

Readers who want to follow SURAKSHA Share Price more closely can use Univest to track live share price movements, valuation ratios, sector comparisons and broader market context in one place. SURAKSHA Share Price Today is only one part of the picture; investors also watch market capitalisation, P/E Ratio, P/B Ratio, ROE, ROCE, 52 Week levels, peer metrics and ongoing stock performance.

Univest helps users organise those data points into a clearer market view without reducing the story to a single-day move. For active users tracking SURAKSHA Stock News, SURAKSHA Latest News and SURAKSHA Shareholding Pattern updates, the platform is designed to keep price action, financial analysis and sector positioning visible together as the stock remains in focus.

Frequently Asked Questions

What is the latest SURAKSHA Share Price Today?

Ans. SURAKSHA Share Price Today was Rs 306 at the time of this update. The stock was up Rs 35.55, or 13.14%, from its previous close of Rs 270.45 in a strong single-session move.

Why is SURAKSHA Share Price rising today?

Ans. The supplied market data confirms that SURAKSHA Share Price rose 13.14% today with active volume of 11,71,023 shares. However, the verified dataset establishes the price event itself and does not identify a company-specific catalyst.

How much did SURAKSHA DIAGNOSTIC LIMITED stock gain today?

Ans. SURAKSHA DIAGNOSTIC LIMITED gained Rs 35.55 in today’s session. That translates into a 13.14% share price rise from the previous close of Rs 270.45 to the current traded price of Rs 306.

What were the day high, day low and opening price for SURAKSHA?

Ans. The stock opened at Rs 274, touched an intraday high of Rs 308.45 and a day low of Rs 271.35. That range shows the stock stayed above the previous close for most of the observed session.

What is the market capitalisation of SURAKSHA DIAGNOSTIC LIMITED?

Ans. SURAKSHA DIAGNOSTIC LIMITED had a market capitalisation of Rs 1,343.94 crore in this update. That places the company in the Small Cap category, which is relevant because today’s gain qualified under its market-cap bracket.

How active was trading volume in SURAKSHA shares today?

Ans. Total traded volume in SURAKSHA shares stood at 11,71,023. Of this, 11,28,409 shares were on NSE and 42,614 shares were on BSE, while the reported turnover linked to the exchange volume source was Rs 1.3 crore.

What valuation ratios does SURAKSHA currently trade at?

Ans. SURAKSHA currently trades at a P/E ratio of 41.35 and a P/B ratio of 5.64. These multiples are above the same-industry median levels of 26.91 for P/E and 2.14 for P/B.

How profitable is SURAKSHA based on ROE and ROCE?

Ans. The company’s ROE is 13.93% and its ROCE is 22.94%. ROE is slightly below the industry median of 14.66%, while ROCE is above the benchmark median of 18.85% in the same industry.

What are the EPS and dividend yield of SURAKSHA DIAGNOSTIC LIMITED?

Ans. SURAKSHA DIAGNOSTIC LIMITED reported EPS of Rs 6.54 and a dividend yield of 0.18. EPS reflects earnings attributable to each share, while dividend yield shows the historical/current payout relative to the stock price.

How does SURAKSHA compare with listed Healthcare peers?

Ans. SURAKSHA sits near GPT Healthcare on market cap, but trades at a higher P/E than GPT Healthcare and Shalby. Its ROCE of 22.94% is stronger than some peers, though not the highest in the group.